News & Views
- Posted By: TreehillPartners
- In: Drug Development, Strategy & Corporate Development
Syneos One and Treehill Partners discuss how Korean biotech companies can optimize for the realities of today, highlighting alternate pathways to global markets and critical success factors...
- Posted By: TreehillPartners
- In: Drug Development, Strategy & Corporate Development
The game continues to change in biotech as continued macroeconomic uncertainty has far reaching implications for the future of the biopharma ecosystem...
- Posted By: TreehillPartners
- In: Drug Development, Strategy & Corporate Development
Continued macroeconomic uncertainty has far reaching implications for the biopharma ecosystem. Access to capital remains low across the industry, and a successful deal with large pharma has become less likely for many...
- Posted By: TreehillPartners
- In: Business Development & Licensing, Dealmaking
Cem Baydar and Paul Verdin from Evaluate are joined by Ali Pashazadeh, Max Baumann, and Mark Mayhew from Treehill Partners to discuss the latest dealmaking data, the pipeline pitfalls to avoid, and more...